Results 11 to 20 of about 2,048,259 (212)

Acquired Elliptocytosis as a Manifestation of Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia [PDF]

Case Reports in Hematology, 2017
Acquired elliptocytosis is a known but rarely described abnormality in the myelodysplastic syndromes (MDS). Here we report the case of an elderly male who was admitted to the hospital with chest pain, dyspnea, and fatigue and was found to be anemic with ...
Jacob D. Kjelland, Denis M. Dwyre, Brian A. Jonas   +2 more
doaj   +3 more sources

Plasmablastic Lymphoma in an Immunocompetent Patient with MDS/MPN with Ring Sideroblasts and Thrombocytosis—A Case Report [PDF]

Case Reports in Hematology, 2018
Plasmablastic lymphoma (PBL) is a rare, aggressive type of B-cell non-Hodgkin lymphoma with the vast majority of patients responding poorly to treatment or progressing shortly thereafter.
Anthi Bouchla, Sotirios G. Papageorgiou, Zoi Tsakiraki, Eirini Glezou, George Pavlidis, Georgia Stavroulaki, Efthimia Bazani, Periklis Foukas, Vasiliki Pappa   +8 more
doaj   +4 more sources

Immune Complex Glomerulonephritis in a Patient with Myelodysplastic Syndrome with Ring Sideroblasts Treated with Luspatercept. [PDF]

Diagnostics (Basel), 2022
Myelodysplastic syndromes (MDS) are a group of clonal myeloid disorders distinguished by dysplastic bone marrow and peripheral blood cells, ineffective hematopoiesis, and an increased risk of developing acute myeloid leukemia (AML).
Delanghe S, Nguyen TQ, Mazure D, Dendooven A, Speeckaert MM.   +4 more
europepmc   +2 more sources

Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis [PDF]

Haematologica, 2012
Background Refractory anemia with ring sideroblasts associated with marked thrombocytosis was proposed as a provisional entity in the 2001 World Health Organization classification of myeloid neoplasms and also in the 2008 version, but its existence as a ...
Julien Broseus, Lourdes Florensa, Esther Zipperer, Susanne Schnittger, Luca Malcovati, Steven Richebourg, Eric Lippert, Jaroslav Cermak, Jyoti Evans, Morgane Mounier, José Maria Raya, François Bailly, Norbert Gattermann, Torsten Haferlach, Richard Garand, Kaoutar Allou, Carlos Besses, Ulrich Germing, Claudia Haferlach, Erica Travaglino, Elisa Luno, Maria Angeles Pinan, Leonor Arenillas, Maria Rozman, Maria Luz Perez Sirvent, Bernardine Favre, Julien Guy, Esther Alonso, Nuhri Ahwij, Andrés Jerez, Sylvie Hermouet, Marc Maynadié, Mario Cazzola, François Girodon   +33 more
doaj   +3 more sources

The E592K variant of SF3B1 creates unique RNA missplicing and associates with high-risk MDS without ring sideroblasts. [PDF]

Blood Adv
Key Points • The E592K variant of SF3B1 induces unique RNA missplicing that is nonoverlapping with other MDS-associated variants.• E592K is associated with elevated blasts, lack of RSs, and decreased survival.
Choi IY, Ling JP, Zhang J, Helmenstine E, Walter W, Tsakiroglou P, Bergman RE, Philippe C, Manley JL, Rouault-Pierre K, Li B, Wiseman DH, Batta K, Ouseph M, Bernard E, Dubner B, Li X, Haferlach T, Koget A, Fazal S, Jain T, Gocke CD, DeZern AE, Dalton WB.   +23 more
europepmc   +2 more sources

Ring sideroblasts and sideroblastic anemias

Haematologica, 2011
The sideroblastic anemias are a heterogeneous group of inherited and acquired disorders characterized by anemia of varying severity and the presence of ring sideroblasts in the bone marrow ...
Mario Cazzola, Rosangela Invernizzi
doaj   +3 more sources

Diagnostic challenges and proposed classification of myeloid neoplasms with overlapping features of thrombocytosis, ring sideroblasts and concurrent del(5q) and <i>SF3B1</i> mutations. [PDF]

Haematologica
Not available.
Kumar J, Lewis NE, Sherpa S, Londono D, Sun X, Gao Q, Arcila ME, Roshal M, Zhang Y, Xiao W, Chan A.   +10 more
europepmc   +2 more sources

Health-Related Quality of Life Outcomes in Patients with Myelodysplastic Syndromes with Ring Sideroblasts Treated with Luspatercept in the MEDALIST Phase 3 Trial. [PDF]

J Clin Med, 2021
Patients with myelodysplastic syndromes (MDS) often experience chronic anemia and long-term red blood cell transfusion dependence associated with significant burden on clinical and health-related quality of life (HRQoL) outcomes.
Oliva EN, Platzbecker U, Garcia-Manero G, Mufti GJ, Santini V, Sekeres MA, Komrokji RS, Shetty JK, Tang D, Guo S, Liao W, Zhang G, Ha X, Ito R, Lord-Bessen J, Backstrom JT, Fenaux P.   +16 more
europepmc   +2 more sources

Chronic myelomonocytic leukemia with ring sideroblasts/SF3B1 mutation presents with low monocyte count and resembles myelodysplastic syndromes with-RS/SF3B1 mutation in terms of phenotype and prognosis. [PDF]

Front Oncol
Introduction Chronic myelomonocytic leukemia (CMML) and myelodysplastic syndromes (MDS) with ring sideroblasts (RS) or SF3B1 mutation (MDS-RS/SF3B1) differ in many clinical features, but share others, such as anemia.
Xicoy B, Pomares H, Morgades M, Germing U, Arnan M, Tormo M, Palomo L, Orna E, Della Porta M, Schulz F, Díaz-Beya M, Esteban A, Molero A, Lanino L, Avendaño A, Hernández F, Roldan V, Ubezio M, Pineda A, Díez-Campelo M, Zamora L.   +20 more
europepmc   +2 more sources

A diagnostic pitfall in iron-refractory microcytic hypochromic anemia with acquired ring sideroblasts initially treated as iron deficiency anemia—a case report [PDF]

Frontiers in Medicine
Microcytic hypochromic anemia is commonly presumed to represent iron deficiency anemia (IDA) at initial presentation. However, failure to respond to iron supplementation and iron indices inconsistent with IDA should prompt early diagnostic reassessment ...
Xiaoqi Liu, Juning Ma, Anning Song, Sheng Yang, Mingxia Li, Jing Yang   +5 more
doaj   +2 more sources